1-4 of 4
Emre Yucel, PhD MSc, MBA, BSPharm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2211.
https://doi.org/10.1182/blood-2019-123743
Published: 2019
Journal Articles

Value of Digital Patient Reported Outcomes (PROs) - Long-Term Management of Treatment Fatigue in Relapsed or Refractory Multiple Myeloma

Noa Biran, MD, Emre Yucel, PhD MSc, MBA, BSPharm, Robin Anthony Kouyaté, PhD, Gillian McGovern, MPH, Antoinette Schoenthaler, EdD, Olivia Durling, BS, Rashmi Unawane, MBBS, Andrew Schutt, MSc, Sumeet Panjabi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3439.
https://doi.org/10.1182/blood-2019-123154
Published: 2019
Journal Articles

A Mixed Methods Approach to Generate Meaningful Change Estimates for the EORTC QLQ-MY20

Emre Yucel, PhD MSc, MBA, BSPharm, Andrew Trigg, MSc, Kate Sully, PhD, Amelia Harper, Nicola Bonner, MSc, Nina Shah, MD, Sumeet Panjabi, PhD, Kim Cocks
Journal: Blood
Blood (2018) 132 (Supplement 1): 5912.
https://doi.org/10.1182/blood-2018-99-116746
Published: 2018
Journal Articles

Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US

May Hagiwara, PhD, Thomas Delea, MBA, MSIA, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Rafael Fonseca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2018-99-117230
Published: 2018